A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

Sarasota Memorial Health Care System (SMH) reported that 75% of lung cancers diagnosed through an innovative early detection program at SMH's Brian D. Jellison Cancer Institute in 2025 were found at ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...

A model integrating deep learning with clinical and epidemiologic data may significantly improve lung cancer risk prediction based on LDCT screening.

Robotic-assisted bronchoscopy with embedded digital tomosynthesis achieved tool-in-lesion, confirmed via cone beam CT, in nearly all patients with peripheral pulmonary nodules, according to data ...

From 2019 to 2024, there was an increase in early lung cancer detection and decrease in local/advanced diagnosis.

Researchers have identified a new method for analyzing chest CT scans that may help physicians better understand the different forms of sarcoidosis, a complex inflammatory lung disease that affects ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...

Five poster presentations span lung cancer early detection, immunotherapy response prediction, cancer subtyping, treatment monitoring, and next-generation ...